Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition by Nardelli, Tarlliza R. et al.
UNIVERSIDADE ESTADUAL DE CAMPINAS
SISTEMA DE BIBLIOTECAS DA UNICAMP
REPOSITÓRIO DA PRODUÇÃO CIENTIFICA E INTELECTUAL DA UNICAMP
Versão do arquivo anexado / Version of attached file:
Versão do Editor / Published Version
Mais informações no site da editora / Further information on publisher's website:
https://jme.bioscientifica.com/view/journals/jme/61/1/JME-16-0257.xml
DOI: 10.1530/JME-16-0257
Direitos autorais / Publisher's copyright statement:
©2018 by BioScientifica. All rights reserved.
DIRETORIA DE TRATAMENTO DA INFORMAÇÃO
Cidade Universitária Zeferino Vaz Barão Geraldo




http://jme.endocrinology-journals.org © 2018 Society for Endocrinology
Printed in Great Britain
Published by Bioscientifica Ltd.




Prolactin protects against cytokine-induced 
beta-cell death by NFκB and JNK inhibition
Tarlliza R Nardelli1, Emerielle C Vanzela1, Keli C Benedicto1, Flora Brozzi2, André Fujita3, Alessandra K Cardozo2, 
Décio L Eizirik2, Antonio C Boschero1,* and Fernanda Ortis4,*
1Department of Structural and Functional Biology, Laboratory of Endocrine Pancreas and Metabolism, Institute of Biology, University of Campinas 
(UNICAMP), Campinas, Brazil
2ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles (ULB), Brussels, Belgium
3Department of Computer Science, Institute of Mathematics and Statistics, University of São Paulo (USP), São Paulo, Brazil
4Department of Cell and Developmental Biology, Institute of Biomedical Science (ICB), University of São Paulo (USP), São Paulo, Brazil
Correspondence should be addressed to F Ortis: fortis@usp.br
*(A C Boschero and F Ortis contributed equally to this work)
Abstract
Type 1 diabetes is caused by an autoimmune assault that induces progressive beta-cell 
dysfunction and dead. Pro-inflammatory cytokines, such as interleukin 1 beta (IL1B), 
tumor necrosis factor (TNF) and interferon gamma (IFNG) contribute for beta-cell death, 
which involves the activation of the nuclear factor kappa B (NFκB) and c- Jun N-terminal 
kinase (JNK). Prolactin (PRL), a physiological mediator for beta-cell proliferation, was 
shown to protect beta cells against cytokines pro-apoptotic effects. We presently 
investigated the mechanisms involved in the protective effects of prolactin against 
cytokine-induced beta-cell death. The findings obtained indicate that STAT3 activation 
is involved in the anti-apoptotic role of PRL in rat beta cells. PRL prevents the activation 
of JNK via AKT and promotes a shift from expression of pro- to anti-apoptotic proteins 
downstream of the JNK cascade. Furthermore, PRL partially prevents the activation of 
NFκB and the transcription of its target genes IkBa, Fas, Mcp1, A20 and Cxcl10 and also 
decreases NO production. On the other hand, the pro-survival effects of PRL do not 
involve modulation of cytokine-induced endoplasmic reticulum stress. These results 
suggest that the beneficial effects of PRL in beta cells involve augmentation of anti-
apoptotic mechanisms and, at the same time, reduction of pro-apoptotic effectors, 
rendering beta cells better prepared to deal with inflammatory insults. The better 
understanding of the pro-survival mechanisms modulated by PRL in beta cells can 
provide tools to prevent cell demise during an autoimmune attack or following islet 
transplantation.
Introduction
Type 1 diabetes (T1D) is caused by an autoimmune 
assault that induces progressive beta-cell dysfunction 
and apoptosis, consequently impairing insulin secretion. 
During insulitis, pro-inflammatory cytokines such as 
interleukin 1 beta (IL1B), tumor necrosis factor (TNF) 
and interferon gamma (IFNG), contribute to beta-cell 
failure and death. At the time of diagnosis, it has been 
estimated a 70–80% loss of beta-cell functional mass 
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(Kukreja & Maclaren 1999, Noble 2015). Beta-cell loss 
in T1D is probably slow and progressive, suggesting that 
preventing beta-cell death is possible.
It has been previously shown that prolactin (PRL) has 
beneficial effects on pancreatic islets during pregnancy or 
following in vitro exposure (Boschero et al. 1993, Crepaldi 
et al. 1997, Cunha et al. 2007). Activation of the PRL receptor 
is important to increase beta-cell mass and maintain 
physiological glucose tolerance during pregnancy (Amaral 
et al. 2004), and decrease the expression of pro-apoptotic 
genes (Bordin et al. 2004). These biological effects require 
the participation of receptor-associated kinases, mainly 
through the JAK/STAT pathway (Bole-Feysot et al. 1998).
PRL protects human islets against inflammatory 
cytokine-mediated apoptosis, and this seems to be at least 
in part mediated by inhibiting the cell death pathways 
controlled by the pro-apoptotic BCL2 family members 
(Terra et al. 2011). The members of this family of proteins 
are grouped into the following three categories: pro-
survival (BCL2, BCLxl, MCL1, BCLw and A1), pro-
apoptotic (BAX, BAK and BOK) and BH3-only proteins, 
which are also pro-apoptotic and divided in sensitizers 
(DP5, BIK, NOXA and BAD) and activators (BIM, PUMA 
and BID) (Kim et al. 2006). When the expression of BH3-
only sensitizers increases, they directly bind and inhibit 
the pro-survival members, releasing the activators. Once 
free, the activators bind and activate the pro-death 
members to form pores in the mitochondria, inducing 
cytochrome c release (Kim et al. 2006). In beta cells, JNK 
is also involved in the activation of the mitochondrial 
pathway of apoptosis through cJUN phosphorylation, 
DP5 expression and downregulation of MCL1 (Gurzov 
et al. 2008, 2009, Allagnat et al. 2011).
Many of the genes modified by cytokines in beta cells 
are regulated by the transcription factor nuclear factor 
kappa B (NFκB), which, directly or indirectly, controls 
the expression of proteins involved in the endoplasmic 
reticulum (ER) stress (via NO production in the case of rat 
beta cells) and cell death (Cardozo et al. 2001a, Darville 
et  al. 2004). The canonical process of NFκB activation 
is initiated by the phosphorylation of the inhibitor of 
kappa B (IkB), leading to ubiquitination and proteasome 
degradation. This allows the nuclear translocation of NFκB 
and increases the transcription of target genes (Chiu et al. 
2009). The transcriptional activity of NFκB can also be 
regulated by post-translational mechanisms (Vermeulen 
et  al. 2002, Hayden & Ghosh 2008). Moreover, pro-
inflammatory cytokines lead to a decreased expression of 
the PRL receptor, reducing the capacity of the beta-cell to 
recover after an autoimmune assault (Kutlu et  al. 2003, 
Ortis et al. 2010), but the nature of the crosstalk between 
PRL signaling and the inflammatory response regulated 
by NFκB (or other pathways) induced by cytokines remain 
to be clarified.
We have presently identified novel specific targets 
of PRL in beta cells in the context of inflammation. 
The findings obtained indicate that PRL exerts an anti-
apoptotic role in rat beta cells exposed to pro-inflammatory 
cytokines potentially through STAT3. PRL induces AKT 
phosphorylation and consequentially prevents the 
cytokine-dependent JNK activation, promoting the 
differential expression of anti- and pro-apoptotic proteins 
downstream of the JNK cascade. Moreover, PRL partially 
prevents the activation of NFκB and the transcription of 
its target genes IkBa, Fas, Mcp1, A20 and Cxcl10.
Materials and methods
Culture of rat islets and INS-1E cells
Wistar rats were used according to the rules of the Brazilian 
Regulations for Animal Care with approval of the Ethical 
Committee for Animal Experiments of the UNICAMP, 
Campinas, Brazil. Pancreatic islets were isolated from 
adult female Wistar rats as described (Vanzela et al. 2010). 
The islets were maintained in RPMI-1640 culture medium 
containing 5.6 mmol/L glucose and 10% v/v of fetal bovine 
serum (FBS) for 24 h prior to treatment. Insulin-producing 
INS-1E cells (Asfari et al. 1992, Janjic et al. 1999), a kind 
gift from Prof. C Wolheim (Centre Médical Universitaire, 
Geneva, Switzerland), were cultured in RPMI-1640 
medium and supplemented with 5% v/v of FBS, HEPES 
10 mmol/L, penicillin 100 U/mL, streptomycin 100 μg/
mL, sodium pyruvate 1 mmol/L and 2-mercaptoethanol 
50 μmol/L in the presence of 11 mmol/L glucose.
Cell treatment and NO measurement
Rat islets were cultured in RPMI medium; containing 
5.6 mmol/L glucose, 1% v/v of FBS and 5% w/v of BSA, with 
0.5 μg/mL of PRL or vehicle (0.01 mmol/L NaHCO3 + 0.3% 
w/v BSA) for 24 h, and then challenged with 10 U/mL of 
human recombinant IL1B (R&D Systems) and 1000 U/mL 
of rat recombinant IFNG (R&D Systems) for additional 
48 h. For the treatment of INS-1E cells with PRL and 
cytokines, cells were maintained in a medium with 1% 
w/v of BSA and 5.6 mmol/L glucose without FBS. The 
experiments were performed after 24 h pre-treatment with 
PRL (0.5 μg/mL) or vehicle and 24-h subsequent exposure 
to 10 U/mL of human recombinant IL1B (R&D Systems) 
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or 1600 U/mL of rat recombinant TNF (Invitrogen) 
combined with 100 U/mL of rat recombinant IFNG (R&D 
Systems). PRL or vehicle were also kept in the medium 
during cytokine exposure in both INS-1E and rat islets. 
INS-1E cells exposed to IL1B + IFNG were also used in the 
time course studies. Nitric oxide (NO) was measured as 
accumulated nitrite in the medium by the Griess reaction 
(Green et al. 1982, Schulz et al. 1999). The Wortmannin 
(Sigma-Aldrich), a specific inhibitor of PI3 kinase, used 
to decrease the phosphorylation of AKT, was dissolved in 
DMSO and used in INS-1E cells at 250 nmol/L, based on 
dose–response experiments (data not shown).
Assessment of apoptosis
The percentage of apoptotic cells was determined by 
the following methods: (A) after 15 min incubation 
with the DNA-binding dyes Hoechst 33342 (5 μg/mL; 
Sigma-Aldrich) and propidium iodide (5 μg/mL; Sigma-
Aldrich), the viable and apoptotic nuclei were counted 
by two independent observers, in which one of them was 
unaware of sample identity (Ortis et al. 2006); (B) by the 
Guava Nexin Reagent kit (Merck Millipore), in which cells 
positive for annexin V were detected by flow cytometry 
(Guava easyCyte 8HT) according to the manufacturer’s 
protocol and (C) by Western blot for cleaved caspase 3 
(see details below). The figures were expressed by control 
values, equal to one, to better visualize the cell death 
induction.
Western blot assay
After cell culture and treatment, the cells were lysed using 
a Laemmli sample buffer. The total protein was fractioned 
in an 8–12% SDS-PAGE and transferred to a nitrocellulose 
membrane. Immunoblot analysis was performed using the 
specific antibodies for the protein of interest: phospho-
SAPK/JNK (Thr183/Tyr185), phospho-c-JUN (Ser63), 
cleaved CASPASE 3, phospho-STAT3, STAT3, PUMA 
(Cell Signaling); iNOS (Abcam); phospho-AKT (ser473), 
phospho-AKT (thr308) and IKBA (Santa Cruz), followed 
by the incubation with the appropriate horseradish 
peroxidase-conjugated secondary antibody (Thermo 
Scientific). The protein intensity was detected by an 
ImageQuant LAS 4000 (GE Healthcare Bio-Sciences) after 
the chemiluminescent reaction with the SuperSignal West 
Femto Chemiluminescent Substrate (Thermo Scientific), 
according to the manufacturer instructions. The intensity 
values for the proteins were quantified using ImageQuant 
TL 7.0 Software (GE Healthcare Bio-Sciences), corrected 
by the housekeeping protein alpha tubulin (aTubulin) 
(Sigma-Aldrich) to confirm similar protein loading and 
normalized by the control condition. Notice that in this 
case, the control condition is considered to be one. When 
the protein is not induced in the control, no normalization 
was done (to avoid division by zero).
mRNA extraction and real time RT-PCR (qRT-PCR)
Poly(A) + mRNA was isolated from the treated cells using 
the Dynabeads mRNA DIRECTTM kit (Invitrogen). A 
constant amount of the purified mRNA was reverse-
transcribed using 50 U MuLV reverse transcriptase 
(Invitrogen) at 42°C for 60 min in a reaction containing 
1× Buffer (16 mmol/L (NH4)2SO4, 67 mmol/L Tris–HCl 
pH 8.8 (at 25°C) and 0.01% Tween 20), 5 mmol/L MgCl2 
(GeneCraft, Cologne, Germany), 2 mmol/L dNTP mix 
(Eurogentec, Seraing, Belgium), 2.5 μmol/L random 
primers and 20 U RNAse inhibitor (Invitrogen). The real-
time RT-PCR amplification reactions were performed 
using an iQ SYBR Green Supermix on Rotor-Gene Q 
(Qiagen), and the concentration of the gene of interest was 
calculated as copies per microliter using a standard curve. 
Gene expression values in INS-1E cells were corrected by 
the housekeeping gene Gapdh.
Promoter reporter assay
Cells were co-transfected using Lipofectamine 2000 
(Invitrogen) with the pRL-CMV internal control encoding 
Renilla (Promega) and the pNFκB-Luciferase (BD 
Biosciences) (Ortis et al. 2008). After transfection (16 h), 
the cells were treated as described earlier. The luciferase 
activity was analyzed using the Dual-Luciferase Reporter 
Assay System kit (Promega), according to the manufacturer 
instructions. The luciferase activity values were corrected 
by the values of the internal control pRL-CMV of each 
experiment.
Small interfering RNA (siRNA) treatment
Two different siRNAs against STAT3 (Sigma-Aldrich) 
were used to knock down the expression of the target 
gene. Allstars Negative Control siRNA (Qiagen) was used 
as a negative control. After overnight incubation with 
30 nmol/L of siRNA using 1 μL per well Lipofectamine 
RNAiMAX, lipid reagent (Invitrogen), the transfection 
medium was replaced by a regular culture medium for cell 
recovery. After 48 h, the cells were exposed to treatment 
as described earlier.
Downloaded from Bioscientifica.com at 02/27/2021 08:32:47PM
via Unicamp, Univ Estadual de Campinas, Universidade Estadual de Campinas, Universidade Estadual Campinas and FT UNICAMP - UNIVERSIDADE ESTADUAL DE CAMPINAS
https://doi.org/10.1530/JME-16-0257
http://jme.endocrinology-journals.org © 2018 Society for Endocrinology
Printed in Great Britain
Published by Bioscientifica Ltd.
28T R Nardelli et al. PRL protects stressed beta cells 61 1:Journal of Molecular 
Endocrinology
Statistical analysis
For expression comparison analysis, we used a paired t-test 
on the log-transformed data. A nominal P-value threshold 
(without correction for multiple tests) of 0.05 was 
considered to be statistically significant. Notice that since 
we applied the paired t-test on the log-transformed data, 
the effects of data normalization by the control condition 
is only for visual inspection. For the statistical analysis, 
the normalization has no effect because the data are log 
transformed. For illustration, consider that we would like to 
test whether (with PRL/control)/(without PRL/control) = 1. 
By applying the log-transform, it is equivalent to test log 
(with PRL) = log (without PRL). It can be tested by a t-test 
because the logarithm is a monotonic transformation. The 
choice for the t-test rather than the usual factorial analysis 
of variance is because of issues of heteroskedasticity.
Results
PRL prevents the apoptosis induced by pro-
inflammatory cytokines
Exposure of INS-1E cells for 24 h to cytokines increased 
the prevalence of apoptotic cells (Cardozo et  al. 2001a, 
Ortis et al. 2006, Allagnat et al. 2011), which is confirmed 
by three different methods (Fig.  1A, B and C). The pre-
treatment of these cells with PRL prevented cell death 
(Fig. 1A and B) and partially the cleavage of CASPASE 3 
(Fig. 1C), which was still observed after 48 h of cytokines 
treatment. Of note, the beneficial effect of PRL was also 
observed in control cells that were not exposed to cytokines 
(Fig. 1A and B). Because the results were similar for both 
cytokine combinations, the subsequent experiments were 
performed using only IL1B + IFNG. Importantly, the pre-
treatment with PRL was also efficient in preventing (by 
~40%) the activation of CASPASE 3 induced by cytokines 
in rat islets (Fig. 1D).
STAT3 potentially mediates the beneficial effects 
of PRL
We next evaluated the impact of PRL on the expression 
of STAT3 (Bordin et  al. 2004, Anhe et  al. 2007) and 
its phosphorylation (DaSilva et  al. 1996). The STAT3 
phosphorylation was induced by PRL treatment as 
observed after 15 min to 8 h of PRL exposure (Fig.  2A 
and B), confirming the regulatory role of PRL on STAT3 
activation. To test whether STAT3 was involved in the 
Figure 1
PRL prevents apoptosis induced by pro-
inflammatory cytokines in rat islets and INS-1E 
cells. INS-1E cells (A, B and C) or rat islets (D) were 
pre-cultured with a vehicle or PRL and then 
treated with IL1B or TNF in combination with 
IFNG for 24 h (INS-1E), 48 h (rat islets) or for the 
time point indicated in the figure. (A) Apoptosis 
determined by percentage of Annexin V-positive 
cells of 5 independent experiments, normalized 
for the respective control (considered as one), 
showed as mean ± s.e.m. (B) Percentage of 
apoptotic cells determined by DNA-binding dyes 
Hoechst and propidium iodide, n = 2 (TNF) to n = 7, 
normalized for the respective control (considered 
as one), showed as mean ± s.e.m. (C and D) 
Western blot for INS-1E cells (C) and rat islets (D) 
cleaved CASPASE 3. One representative Western 
blot of 3 (islets) to 5 (INS-1E) independent 
experiments is shown, graphs showed the values 
corrected by aTubulin and normalized for the 
respective control values (considered as one). 
Results are means ± s.e.m. *P ≤ 0.05, **P < 0.01 or 
***P < 0.001 for log-transformed paired t-test of 
vehicle vs PRL.
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beneficial effects of PRL, two specific siRNAs (siSTAT3-1 
and siSTAT3-2) were used to suppress STAT3 in INS-1E 
cells. The first siRNA was not able to significantly decrease 
expression of STAT3 (Fig. 2C and D), with no significant 
effect on cell viability (Fig. 2E). A better knockdown (KD) 
(60% inhibition) was observed with the second siRNA, 
namely siSTAT3-2 (Fig.  2C and D), which abolished 
the prevention of apoptosis induced by PRL following 
exposure to cytokines (Fig. 2E).
PRL modifies the activation of JNK and decreases 
cJUN-dependent Dp5 expression
One of the mechanisms by which cytokines contribute 
to beta-cell apoptosis is via JNK activation (Ammendrup 
et  al. 2000), and consequent JNK/cJUN-dependent Dp5 
expression (Gurzov et  al. 2009). Pre-treatment with PRL 
modified the pattern of JNK activation after exposure to 
cytokines in the continuous presence of PRL, with an 
early increase in the phosphorylation of JNK after 30 min, 
followed by a decrease in JNK phosphorylation after 8 
and 24 h, compared with IL1B + IFNG alone (Fig. 3A). In 
addition, INS-1E cells pre-exposed to PRL and then treated 
with cytokines for 8 or 24 h, in the continuous presence 
of PRL, displayed reduced phosphorylation of cJUN (8 h) 
(Fig. 3B), a downstream indicator of JNK activity, and Dp5 
expression (24 h) (Fig.  3C), suggesting that PRL-induced 
inhibition of JNK phosphorylation plays a key role in 
preventing beta-cell death.
PRL regulates the expression of pro- and  
anti-apoptotic BCL2 family members
We next evaluated the involvement of PRL in modulating 
the pro-death BH3-only proteins BIM and PUMA, known to 
be activated downstream of Dp5 (Gurzov et al. 2009, Gurzov 
& Eizirik 2011). After 24 h of treatment, IL1B + IFNG increased 
Bim (Fig. 4A) and Puma mRNA (Fig. 4C) and PUMA protein 
expression (Fig. 4D and E). Although PRL did not prevent 
cytokine-induced total Bim mRNA expression (Fig.  4A), it 
decreased the expression of its most pro-apoptotic isoform, 
namely Bim small (BimS), in untreated condition and 
marginally following cytokine condition (Fig. 4B). PRL also 
decreased cytokine-mediated PUMA expression at the mRNA 
Figure 2
The STAT3 pathway is involved in PRL protective 
effects against cytokine-induced apoptosis. (A 
and B) INS-1E cells were treated with PRL for the 
time points indicated in the figure. Protein cell 
lysates were used in Western blot for 
phosphorylated STAT3 (pSTAT3) and aTubulin. (A) 
One representative Western blot of 3 
independent experiments. (B) Optical density 
measurements of the blots corrected by aTubulin 
are expressed as mean ± s.e.m. and normalized by 
the control value in each experiment (considered 
as one). ‡P < 0.05 or ‡‡P < 0.01 for log-transformed 
paired t-test of each time point vs control (time 
point zero). (C, D and E) INS-1E cells were 
transfected overnight with two specific siRNAs for 
STAT3 (siSTAT3-1 and siSTAT3-2) or a control siRNA 
(siCTL). 48 h after transfection, cells were treated 
for 24 h with vehicle or PRL, then with IL1B + IFNG 
for additional 24 h. (C and D) Protein cell lysates 
were used in Western blot for STAT3 and 
aTubulin. (C) One representative Western blot of 
3 independent experiments. (D) Optical density 
measurements of bands corresponding to STAT3 
corrected by aTubulin and normalized by the 
control value in each experiment (considered as 
one) are expressed as mean ± s.e.m. †P < 0.05 for 
log-transformed paired t-test of each siRNA vs 
siCTL. (E) Apoptosis determined by percentage of 
annexin V positive cells of 4 independent 
experiments, results were normalized by the 
control value in each experiment (considered as 
one). Data are means ± s.e.m. *P ≤ 0.05 or  
** P < 0.01 for log-transformed paired t-test of 
vehicle vs PRL.
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(Fig. 4C) and at protein levels (Fig. 4D and E). Importantly, 
PRL alone increased the expression of the pro-survival BCL-2 
family protein BCLxl in a time-dependent manner and also 
increased (30%) the expression of this protein after 8 h of 
exposure to cytokines compared with cells treated with 
IL1B + IFNG alone (data not shown).
PRL-decreased JNK activation is dependent of AKT
PRL induces activation of AKT in pancreatic beta cells 
(Amaral et al. 2004), which was confirmed in our model 
by the observed increased phosphorylation of both serine 
and threonine residues of AKT in PRL-treated INS-1E cells 
(Fig. 5A and B). Cytokines have been described to impair 
the signal transduction of this pro-survival pathway 
(Storling et  al. 2005). In line with this, after 30 min of 
IL1B + IFNG exposure there was a clear decrease in the 
phosphorylation of AKT at serine 473 in both vehicle- 
and PRL-treated cells (Fig.  5A). At later time points, 
however, PRL was able to maintain and even increase 
AKT phosphorylation in both residues in spite of the 
continuous presence of cytokines (Fig. 5A and B), which 
Figure 3
PRL modulates the activation of JNK/cJUN-
dependent Dp5 expression in INS-1E cells. INS-1E 
cells were treated for 24 h with PRL or vehicle and 
then with IL1B + IFNG for 8 h (B) or 24 h (C) or for 
the time points indicated in the figure (A) in the 
continuous presence of PRL. Protein cell lysates 
were used in Western blot for phosphorylated 
JNK (pJNK), phosphorylated cJUN (pcJUN) and 
aTubulin. One representative Western blot of 7–8 
independent experiments and optical density 
measurements of the blots for pJNK (A) and 
pcJUN (B), corrected by aTubulin and normalized 
by the control in each experiment (considered as 
one) are expressed as mean ± s.e.m. (C) The 
expression of Dp5 was assessed in 4 independent 
experiments by qRT-PCR, corrected by the 
housekeeping gene Gapdh and expressed as 
mean ± s.e.m. *P ≤ 0.05, **P < 0.01 or ***P < 0.001 
for log-transformed paired t-test of vehicle vs PRL 
at the same time point.
Figure 4
PRL downregulates the expression of pro-apoptotic BCL2 family members. INS-1E cells were pretreated for 24 h with vehicle or PRL and then with 
IL1B + IFNG for additional 24 h in the continuous presence of PRL. The expression of (A): Bim, (B): Bim small (BimS) and (C): Puma was assessed by qRT-PCR 
and corrected by the housekeeping gene Gapdh. The data represent the means ± s.e.m. of 4 independent experiments. (D and E) PUMA expression was 
also analyzed by Western blot. (D) One representative Western blot of 4 independent experiments, (E) optical density measurements of bands 
corresponding to PUMA corrected by aTubulin and normalized by the control in each experiment (considered as one) are expressed as mean ± s.e.m. 
*P < 0.05 or **P < 0.01 for log-transformed paired t-test of vehicle vs PRL.
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Figure 5
PRL upregulates the phosphorylation of AKT, which contributes for the downregulation of JNK. (A and B) INS-1E cells were treated for 24 h with PRL or 
vehicle and then with IL1B + IFNG in the continuous presence of PRL, for the time points indicated in the figure. Protein cell lysates were used in Western 
blot analysis of (A) phospho-AKT serine (pAKT ser) and (B) threonine (pAKT thr). One representative Western blot of 4 (A) to 5 (B) independent 
experiments is shown and the optical density measurements of the specific bands corrected by aTubulin and normalized by the control in each 
experiment (considered as one) are expressed as mean ± s.e.m. *P < 0.05 or **P < 0.01 for log-transformed paired t-test of vehicle vs PRL at each time point. 
The inset depicts the area under the curve (AUC) for its respective graphs. (C, D and E) INS-1E cells were pretreated for 2 h with 250 nmol/L of 
Wortmannin or DMSO, then treated for 24 h with PRL or vehicle followed by 8 h of exposure to IL1B + IFNG in the continuous presence of Wortmannin 
and PRL. The expression of (C) pAKT ser, (D) pAKT thr and (E) pJNK was assessed by Western blot. One representative Western blot of 5 (C and D) and 
5–9 (E) and the optical density measurements of the specific bands corrected by aTubulin and normalized by the control in each experiment (considered 
as one) are expressed as means ± s.e.m. $P < 0.05 or $$P < 0.01 for log-transformed paired t-test of DMSO vs Wortmannin in each condition (C and D); and 
**P < 0.01 for log-transformed paired t-test of vehicle vs PRL (E). (F, G and H) Isolated rat islets were treated for 24 h with PRL or vehicle and then with 
IL1B + IFNG for the time points indicated in the figure and (G) pAKT ser and (H) pJNK were assessed by Western blot. One representative Western blot of 
5 independent experiments are shown with the optical density measurements of the specific bands corrected by aTubulin and normalized by the control 
in each experiment (considered as one) expressed as means ± s.e.m. *P ≤ 0.05 for log-transformed paired t-test of vehicle vs PRL in each time point.
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is confirmed by the measurement of the area under the 
curve in each graph (Fig. 5A and B, smaller graph).
AKT is a modulator of JNK activation (Humphrey et al. 
2014). We next evaluated whether the observed decrease 
in cytokine-induced JNK phosphorylation, induced 
by PRL (Fig.  3A), was caused by AKT activation. INS-1E 
cells treated with Wortmannin, a PI3K/AKT inhibitor, 
displayed ~40% less phosphorylation of both serine and 
threonine AKT than DMSO treated cells (Fig. 5C and D), 
and under this condition pre-treatment with PRL failed to 
decrease cytokine-induced JNK phosphorylation (Fig. 5E). 
Although PRL was able to promote a small increase in AKT 
phosphorylation in isolated rat islets exposed to cytokines 
at 30 min (Fig. 5F and G), this was not accompanied by 
modulation of cytokine-induced JNK activation (Fig.  5F 
and H), at least in the tested conditions.
PRL attenuates the activation of NFκB by cytokines 
in beta cells
In parallel to JNK activation, IL1B also induces NFκB 
activation, a key signal for induction of beta-cell apoptosis 
(Heimberg et al. 2001, Ortis et al. 2006). We thus assessed 
the transcriptional activation of NFκB using a luciferase 
reporter assay regulated by 6 NFκB binding sites. INS-1E 
cells treated with IL1B + IFNG presented increased 
activation of NFκB in a time-dependent manner (Fig. 6A), 
and pre-treatment with PRL impaired this activation, 
with a ~40% decrease after 16 h of exposure to cytokines 
(Fig.  6A). These findings were confirmed by analyzing 
NFκB target genes in beta cells (Fig. 6B, C, D, E and F). 
Thus, PRL partially prevented cytokine-induction of IkBa, 
Fas, Mcp1 and A20 by 35–50% (Fig. 6B, C, D and E) and 
Cxcl10 by ~70% (Fig. 6F). Although PRL did not change 
cytokine-induced iNOS expression in isolated rat islets 
(Fig. 6G), it decreased this protein in INS-1E cells (Fig. 6H), 
which was correlated with a decrease in NO production 
as measure by medium nitrite accumulation (Fig. 6I), and 
induced a delay in IkBa protein replenishment after its 
complete degradation by cytokine exposure (Fig.  6J). In 
rat beta cells, the activation of ER stress is NO dependent 
(Brozzi et al. 2015); but despite the partial inhibition of 
NO production (Fig.  6I) PRL did not prevent cytokine-
induced ER stress (data not shown).
Discussion
PRL exerts its anabolic effects on different cell types 
mainly by stimulating the JAK/STAT pathway. Three 
members of the STAT family have been identified to 
promote the activation of the PRL-responsive genes, 
namely STAT1, STAT3 and STAT5 (DaSilva et  al. 1996, 
Bole-Feysot et al. 1998). STAT5 has been described to be 
the main mediator of the protective effects of PRL and 
growth hormone in human and rat beta cells exposed to 
stressful conditions (Jensen et al. 2005, Terra et al. 2011); 
while STAT3 has also been suggested to mediate the 
beneficial effects of PRL on insulin secretion in pancreatic 
beta cells (Anhe et al. 2007). We presently show that PRL 
induces STAT3 activation in INS-1E cells, which is related 
to the observed protective effects of PRL against cytokine-
induced apoptosis.
Cytokines induce activation of JNK in rat and human 
beta cells (Ammendrup et al. 2000, Brozzi et al. 2015). The 
involvement of JNK in beta-cell death can be dependent 
(Ortis et  al. 2012) or independent of NFκB activation 
(Gurzov et  al. 2008). JNK contributes for the activation 
of the mitochondrial pathway of apoptosis (Gurzov et al. 
2008) through cJUN phosphorylation and Dp5 expression 
(Gurzov et  al. 2009). DP5 inactivates the anti-apoptotic 
protein BCLxl, leading to the release of PUMA and BIM. 
These two BH3-only activators induce BAX translocation 
to the mitochondria, which releases cytochrome c and 
triggers the activation of caspases 9 and 3 that execute the 
intrinsic apoptotic pathway (Gross et al. 1998, 1999). We 
presently demonstrate that PRL decreases the expression 
of both cJUN and Dp5 and the downstream pro-apoptotic 
proteins PUMA and BimS, while it increases the anti-
apoptotic protein BCLxl expression. The net result is 
a shift from a pro- to an anti-apoptotic balance, which 
explains the observed protection induced by PRL against 
cytokine-induced beta-cell death.
In order to clarify the mechanism by which PRL 
modulates JNK, we assessed the role of AKT kinase in 
this context. The AKT pathway is an important anti-
apoptotic signal that inhibits the MAPK cascade involved 
in cytokine-induced JNK activation (Franke et  al. 1997, 
Humphrey et  al. 2014), and we have previously shown 
that PRL induces PI3K/AKT during pregnancy (Amaral 
et  al. 2004). We presently observed that PRL increases 
the phosphorylation of AKT and demonstrated that the 
inhibition of this AKT activation prevent PRL inhibitory 
effects and even increases cytokine-induced JNK 
activation. These observations confirm that AKT is one of 
the signals that mediate the beneficial effects of PRL on 
beta-cell survival.
NFκB is an important transcription factor involved in 
the induction of beta-cell death by cytokines (Giannoukakis 
et al. 2000, Baker et al. 2001, Heimberg et al. 2001, Ortis 
et al. 2006). During the activation of NFκB signaling, IkBa 
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is rapidly degraded allowing the nuclear translocation of 
NFκB (Hayden & Ghosh 2008, Chiu et  al. 2009). In the 
nucleus this transcription factor triggers the transcription 
of several target genes, including Fas, Mcp1 (Cardozo et al. 
2001b, Ortis et al. 2008), Cxcl10 (Cardozo et al. 2003, Eldor 
et al. 2013), A20 and IkBa (Shembade & Harhaj 2012). The 
first three genes are involved in the amplification of the 
inflammatory process, while A20 and IkBa act as negative 
regulatory elements retaining NFκB in the cytoplasm and 
preventing its translocation to the nucleus (Shembade & 
Harhaj 2012). We presently observed that PRL directly 
reduces the promoter activity of NFκB after a cytokine 
stimulus. This is accompanied by attenuation of the 
pro-inflammatory responses downstream of NF-κB, as 
evidenced by the observed down regulation of IkBa, Fas, 
Mcp1, A20 and Cxcl10 expression.
Figure 6
PRL decreases the NFκB activation induced by 
cytokines. (A) INS-1E cells were transfected for 
five hours with the NFκB reporter and a pRL-CMV 
plasmid used as internal control. Sixteen hours 
after transfection, the cells were pretreated with 
PRL or vehicle and then with IL1B combined with 
IFNG for the time points indicated in the figure. 
Luciferase was assayed, and the obtained values 
were corrected by the internal control value of 
each experiment. The results are means ± s.e.m. of 
3 independent experiments. (B, C, D, E and F) The 
expression of the NFκB target genes (B) IkBa, (C) 
Fas, (D) Mcp1, (E) A20 and (F) Cxcl10 was assessed 
by qRT-PCR after 24 h of cytokine treatment and 
corrected by the housekeeping gene Gapdh. The 
data represent the means ± s.e.m. of 4 independent 
experiments. Expression of (G) iNOS in rat islets 
(n = 3), (H) iNOS (n = 6) and (J) IkBa (n = 3–4) in 
INS-1E cells were assessed by Western blot 
analysis at the time points indicated in the figure 
(G and J) and 24 h (H). One representative 
Western blot and the optical density 
measurements of the specific bands corrected by 
aTubulin are shown. No normalization (G and H) 
or normalization by control was done in each 
experiment (considered as one) (J). Data are 
shown as means ± s.e.m. (I) The supernatant of 
INS-1E cells treated for 24 h with vehicle or PRL 
and then with IL1B + IFNG for additional 24 h was 
collected for determination of nitrite 
accumulation. *P < 0.05 or **P < 0.01 for 
log-transformed paired t-test of vehicle vs PRL at 
each time point.
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It was previously shown that PRL ameliorates the severity 
of joint inflammation and reduces chondrocyte apoptosis 
in models of inflammatory arthritis, possibly via the JAK2/
STAT3-dependent pathway (Adan et al. 2013). These results 
are consistent with our observation that PRL reduces NFκB 
activity and expression of inflammatory mediators. Of note, 
a constitutively activated form of STAT3 is able to suppress 
NFκB transcriptional activity (Nishinakamura et al. 2007), 
while STAT3 knockdown results in significant elevation 
of NFκB promoter activity (Gong et al. 2014) in other cell 
types. Therefore, the observed decrease in NFκB activation 
induced by PRL could be mediated via STAT3 activation, a 
hypothesis that requires further investigation.
Induction of ER stress by cytokines, via activation of 
NFκB and consequently NO production, is involved in the 
destruction of rat beta cells (Cardozo et al. 2005, Brozzi et al. 
2015). Although we observed a decrease in NO production 
induced by PRL and previous findings demonstrated 
that pregnancy can improve calcium handling in islets 
(Vanzela et al. 2010); a condition that can be related to the 
maintenance of ER homeostasis; here we observed that the 
protective effects of PRL do not involve the attenuation 
of the main ER stress signaling pathways that contribute 
to cytokine-induced beta-cell death (Cardozo et al. 2005).
In conclusion, the present findings suggest that PRL 
increases the ‘apoptosis threshold’ in beta cells by both 
reducing expression/activity of pro-apoptotic effectors 
and augmenting anti-apoptotic mechanisms. These effects 
enable beta cells to better survive in face of inflammation-
induced stress. Understanding the specific pro-survival 
proteins and pathways modulated by PRL might provide 
novel tools to protect beta cells during an autoimmune 
attack or following islet transplantation.
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